Arrigo F.G. Cicero, MD, PhD

President of the Italian Nutraceutical Society (SINut) Associate Professor of Dietary Sciences

Dept. of Medical and Surgical Sciences Alma Mater Studiorum

University of Bologna

Italy

Prof. Manfredi Rizzo, MD, PhD

Associate Professor of Internal Medicine

Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE)

School of Medicine

University of Palermo

Italy

Discusses the use of nutraceuticals for medical conditions such as dyslipidemia, hypertension, insulin resistance, and heart failure

Includes the best clinical evidence supporting the use of nutraceuticals in cardiology

Examines cardiovascular disease epidemiology, risk factors, and the role of dietary patterns

Provides an evidence-based approach for the clinical use of nutraceuticals in the prevention and management of cardiovascular disease

Chapter 1. Introduction to Cardiovascular Disease Epidemiology and Risk Factors.- Chapter 2. Definition of Nutraceuticals (Both Scientific and Legal).- Chapter 3. Evidence-based Approach to Nutraceuticals in Cardiovascular Medicine.- Chapter 4. Dietary Patterns and Cardiovascular Disease Risk: From Epidemiology to Intervention.- Chapter 5. Single Dietary Components and Cardiovascular Disease Risk: From Epidemiology to Intervention.- Chapter 6. Nutraceuticals for Dyslipidemia Management.- Chapter 7. Nutraceuticals for Hypertension Management.- Chapter 8. Nutraceuticals for Management of Insulin Resistance.- Chapter 9. Nutraceuticals Supporting Body Weight Loss.- Chapter 10. Nutraceuticals for Non-alcoholic Fatty Liver Disease Management.- Chapter 11. Nutraceuticals for Homocysteine Reduction.- Chapter 12. Nutraceuticals Supporting Cognitive Function in Mild Cognitive Impairment.- Chapter 13. Nutraceuticals Supporting Heart Function in Heart Failure.- Chapter 14. Nutraceuticals with Potential Adverse Cardiovascular Events or Pharmacological Interaction with Cardiometabolic Drugs.